ABT.SW Abbott (SIX) CHF100.00 intraday: earnings 22 Jan 2026 could shift outlook
ABT.SW stock trades at CHF100.00 intraday as investors position ahead of Abbott Laboratories’ earnings due 22 Jan 2026. The upcoming report will test diagnostics demand and device sales, two core drivers of Abbott’s Healthcare segment. Traders should note the stock’s PE 15.70 and EPS 6.37, which frame expectations for any guidance change. We review valuation, short-term technical cues, and how results could move the SIX-listed Abbott (Switzerland) listing.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
